Completed PHASE2 INTERVENTIONAL 2-arm NCT01512173

Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo

A Randomised, Double Blind, Controlled, Multicentre Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo.

Sponsor: Pierre Fabre Dermatology

Conditions Infantile Hemangioma

Interventions Placebo propranolol gel

Updated 6 times since 2017 Last updated: Oct 29, 2014 Started: Jan 31, 2012 Primary completion: May 31, 2013 Completion: May 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01512173, this PHASE2 trial focuses on Infantile Hemangioma and remains completed. Sponsored by Pierre Fabre Dermatology, it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pierre Fabre Dermatology

Data source: Pierre Fabre Dermatology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Barcelona, Spain , Bordeaux, France , Gdansk, Poland , Lille, France , Lodz, Poland , Lyon Bron, France , Madrid, Spain , Marseille, France , Nantes, France , Paris, France and 6 more locations